Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Imagion Biosystems Ltd. ( (AU:IBX) ).
Imagion Biosystems Ltd. has announced the issuance of 10 million new ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code IBX. This move is part of the company’s strategy to enhance its capital base, potentially strengthening its market position and providing additional resources for ongoing research and development efforts.
The most recent analyst rating on (AU:IBX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Imagion Biosystems Ltd. stock, see the AU:IBX Stock Forecast page.
More about Imagion Biosystems Ltd.
Imagion Biosystems Ltd. operates in the biotechnology industry, focusing on developing innovative diagnostic imaging solutions. The company is known for its advancements in magnetic nanoparticle technology, which aims to improve the early detection of cancer and other diseases.
Average Trading Volume: 9,370,432
Technical Sentiment Signal: Sell
Current Market Cap: A$9.83M
Learn more about IBX stock on TipRanks’ Stock Analysis page.